MARKET

BCRX

BCRX

Biocryst Pharmaceuticals Inc
NASDAQ
7.45
+0.39
+5.52%
After Hours: 7.37 -0.08 -1.07% 19:17 01/17 EST
OPEN
7.04
PREV CLOSE
7.06
HIGH
7.49
LOW
6.96
VOLUME
3.96M
TURNOVER
--
52 WEEK HIGH
8.88
52 WEEK LOW
4.030
MARKET CAP
1.54B
P/E (TTM)
-12.2694
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCRX last week (0113-0117)?
Weekly Report · 1d ago
BioCryst Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 01/13 15:41
BioCryst Pharmaceuticals Price Target Raised to $12.00/Share From $10.00 by Evercore ISI Group
Dow Jones · 01/13 15:41
Evercore ISI Group Maintains Outperform on BioCryst Pharma, Raises Price Target to $12
Benzinga · 01/13 15:31
BioCryst price target raised to $15 from $14 at Needham
TipRanks · 01/13 14:35
BioCryst Pharmaceuticals Price Target Raised to $15.00/Share From $14.00 by Needham
Dow Jones · 01/13 13:36
BioCryst Pharmaceuticals Is Maintained at Buy by Needham
Dow Jones · 01/13 13:36
BioCryst price target raised to $12 from $10 at Evercore ISI
TipRanks · 01/13 13:35
More
About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older.

Webull offers BioCryst Pharmaceuticals Inc stock information, including NASDAQ: BCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCRX stock methods without spending real money on the virtual paper trading platform.